ALK B — Alk-Abello A/S Share News
0.000.00%
- DKK51.65bn
- DKK50.34bn
- DKK6.31bn
Brief: Alk Provides Update On Regulatory Process For The House Dust Mite Allergy Tablet In China
ALK tracks worst day in a year on 2028 margin target miss
Brief: Alk-Abello A/S Alk Says Continues To Target An EBIT Margin Of 25% In 2025
Brief: ALK-Abello Outlook FY EBIT Margin 17-19%
Brief: Alk-Abello Presents Positive Phase 3 Paediatric Trial Data
Europe Research Roundup: Ashtead Technology, DCC, Indra
ALK-Abello shares soar after higher Q1 profit, outlook hike
Brief: Alk-Abello A/S Q1 Total Revenue Increased By 10% In Local Currencies To Dkk 1,351 Mln
Brief: Alk Upgrades Its Full-Year Revenue Outlook, Has Decided To Advance Release Of Its Q1 Results
Brief: ALK-Abello Outlook FY Revenue Growth 10-13%
Europe Research Roundup: Akzo Nobel, Galp, Randstad
Health Rounds: AI may improve skin condition diagnosis, skin tone bias still exists
Brief: ALK-Abello Sees 2024 Revenue Growth Of 9-12% In Local Currencies
Brief: ALK-Abello Q4 Revenue DKK 1,345 Million
Brief: ALK Peanut Tablet Shown To Be Safe, Tolerable For All Dose Levels
Brief: ALK Expands Partnership With Torii In Japan
Hawaiian Holdings shares surge after $1.9 bln buyout deal with Alaska Air
Europe Research Roundup: AstraZeneca, Barclays, BASF SE
ALK-Abello heads for best day in 14 years after Q3 earnings beat